An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

Background: In many countries, the incremental cost-effectiveness ratio (ICER) is used to
assess whether an intervention is worth its costs. At the same time, policy makers often feel …

Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …

Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …

Approaches for cervical cancer prevention are changing. Screening still remains the most
effective method for cervical cancer prevention. Guidelines are moving to an older group of …

Objectives To examine the public health impact of mass vaccination with live attenuated
human rotavirus vaccine (RIX4414) in a birth cohort in India, and to estimate the cost …

The implementation of cytology-based screening programs for precancerous lesions of the
cervix has decreased the incidence of and mortality from cervical cancer in much of the …

Several countries recently added human papillomavirus (HPV) vaccination to cervical
cancer screening in the effort to prevent cervical cancer. They include the Netherlands …

Background Health economic evaluations of interventions in infectious disease are
commonly based on the predictions of ordinary differential equation (ODE) systems or …

Background There is scant information on whether Human Immunodeficiency Virus (HIV)
seropositivity has an influence on the outcome of treatment of precancerous cervical lesions …